Impacts of HER2 immunohistochemical scores on response and outcomes of HER2-positive breast cancers after neoadjuvant therapy.

Yun-Ning Chiu,Chih-Yi Hsu,Pei-Ju Lien,Ta-Chung Chao,Chun-Yu Liu,Yen-Shu Lin,Yu-Ling Wang,Yi-Fang Tsai,Ling-Ming Tseng

Journal of the Chinese Medical Association : JCMA（2023）

引用 3|浏览11

暂无评分

摘要

HER2 IHC score is an independent predictor for outcome. IHC 3+ tumors presented a trend of higher pCR rate and better outcome in HER2-positive breast cancer patients who receive NST.

查看译文

关键词

Breast neoplasm,erbB-2,Immunohistochemistry,Neoadjuvant

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要